Avinger Gains 510(k) Clearance for Pantheris

May 24, 2018

Avinger received 510(k) clearance from the FDA for its lumivascular atherectomy system, Pantheris, an image-guided atherectomy device for treatment of peripheral artery disease.

The system includes a single balloon designed to allow blood flow occlusion and to treat blocked peripheral blood vessels using optical coherence tomography.

An in-process clinical trial is examining the device’s use for treating in-stent restenosis in lower extremity arteries.

Avinger said it plans to launch two versions at initial U.S. sites. The device previously received CE Mark approval in the European Union.

View today's stories